This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Paroxysmal Nocturnal Hemoglobinuria
Information about Paroxysmal Nocturnal Hemoglobinuria: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Paroxysmal Nocturnal Hemoglobinuria
Most recent studies have shown that Paroxysmal Nocturnal Hemoglobinuria shares some biological mechanisms with anemia, anemia-hemolytic, aplastic-anemia, autoimmune-reaction, budd-chiari-syndrome, dysmyelopoietic-syndromes, hematological-disease, hemoglobinuria, hemoglobinuria-paroxysmal, hemolysis-(disorder), hemorrhage, intravascular-hemolysis, leukemia, leukemia-myelocytic-acute, myeloid-leukemia, pancytopenia, thrombosis, venous-thrombosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Paroxysmal Nocturnal Hemoglobinuria, and have been seen in publications frequently: Blood Coagulation, Cell Activation, Cell Death, Cell Growth, Cell Proliferation, Coagulation, Complement Activation, Cytolysis, Excretion, Fibrinolysis, Hypersensitivity, Immune Response, Localization, Methylation, Pathogenesis, Phagocytosis, Platelet Activation, Secretion, T Cell Activation, Transport
Quite a number of genes have been found to play important roles in Paroxysmal Nocturnal Hemoglobinuria, such as ACHE, ASXL1, C3, C5, CD14, CD34, CD55, CD59, CTLA4, FCGR3A, FCGR3B, GNPDA1, GPI, HLA-DQA1, NDUFA2, NOD2, PAFAH1B1, PIGA, TEAD1, YWHAE. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.